Literature DB >> 34894725

IL-1 receptor signaling in podocytes limits susceptibility to glomerular damage.

Jiafa Ren1,2, Xiaohan Lu1, Gentzon Hall1, Jamie R Privratsky3, Matthew J Robson4, Randy D Blakely5, Steven D Crowley1.   

Abstract

Interleukin (IL)-1 receptor type 1 (IL-1R1) activation triggers a proinflammatory signaling cascade that can exacerbate kidney injury. However, the functions of podocyte IL-1R1 in glomerular disease remain unclear. To study the role of IL-1R1 signaling in podocytes, we selectively ablated podocyte IL-1R1 in mice (PKO mice). We then subjected PKO mice and wild-type controls to two glomerular injury models: nephrotoxic serum (NTS)- and adriamycin-induced nephropathy. Surprisingly, we found that IL-1R1 activation in podocytes limited albuminuria and podocyte injury during NTS- and adriamycin-induced nephropathy. Moreover, deletion of IL-1R1 in podocytes drove podocyte apoptosis and glomerular injury through diminishing Akt activation. Activation of Akt signaling abrogated the differences in albuminuria and podocyte injury between wild-type and PKO mice during NTS. Thus, IL-1R1 signaling in podocytes limits susceptibility to glomerular injury via an Akt-dependent signaling pathway. These data identify an unexpected protective role for IL-1R1 signaling in podocytes in the pathogenesis of glomerular disease.NEW & NOTEWORTHY The present study establishes that activation of the receptor for interleukin-1 limits susceptibility to damage to the kidney glomerulus in preclinical mouse models by stimulating Akt signaling cascades inside the podocyte.

Entities:  

Keywords:  apoptosis; interleukin-1; kidney; podocyte; proteinuria

Mesh:

Substances:

Year:  2021        PMID: 34894725      PMCID: PMC8782651          DOI: 10.1152/ajprenal.00353.2021

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  48 in total

1.  An improved method for primary culture of rat podocytes.

Authors:  K Katsuya; E Yaoita; Y Yoshida; Y Yamamoto; T Yamamoto
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

Review 2.  From podocyte biology to novel cures for glomerular disease.

Authors:  Elena Torban; Fabian Braun; Nicola Wanner; Tomoko Takano; Paul R Goodyer; Rachel Lennon; Pierre Ronco; Andrey V Cybulsky; Tobias B Huber
Journal:  Kidney Int       Date:  2019-05-31       Impact factor: 10.612

Review 3.  Podocyte injury and its consequences.

Authors:  Michio Nagata
Journal:  Kidney Int       Date:  2016-03-19       Impact factor: 10.612

4.  Apoptosis by pan-caspase inhibitors in lipopolysaccharide-activated macrophages.

Authors:  S O Kim; K Ono; J Han
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-11       Impact factor: 5.464

5.  Interleukin-1 accounts for intrarenal Th17 cell activation during ureteral obstruction.

Authors:  Jana Pindjakova; Shirley A Hanley; Michelle M Duffy; Caroline E Sutton; Gudrun A Weidhofer; Melinda N Miller; Karl A Nath; Kingston H G Mills; Rhodri Ceredig; Matthew D Griffin
Journal:  Kidney Int       Date:  2011-10-05       Impact factor: 10.612

Review 6.  Potential role of Akt signaling in chronic kidney disease.

Authors:  Aiping Lan; Jie Du
Journal:  Nephrol Dial Transplant       Date:  2014-06-02       Impact factor: 5.992

7.  Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities.

Authors:  Xiaoyu Liu; Daniel P Nemeth; Daniel B McKim; Ling Zhu; Damon J DiSabato; Olimpia Berdysz; Gowthami Gorantla; Braedan Oliver; Kristina G Witcher; Yufen Wang; Christina E Negray; Rekha S Vegesna; John F Sheridan; Jonathan P Godbout; Matthew J Robson; Randy D Blakely; Phillip G Popovich; Staci D Bilbo; Ning Quan
Journal:  Immunity       Date:  2019-01-22       Impact factor: 31.745

8.  Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat.

Authors:  H Y Lan; D J Nikolic-Paterson; W Mu; J L Vannice; R C Atkins
Journal:  Kidney Int       Date:  1995-05       Impact factor: 10.612

9.  Contributions of IL-1beta and IL-1alpha to crescentic glomerulonephritis in mice.

Authors:  Jennifer R Timoshanko; A Richard Kitching; Yichiro Iwakura; Stephen R Holdsworth; Peter G Tipping
Journal:  J Am Soc Nephrol       Date:  2004-04       Impact factor: 10.121

10.  The Players: Cells Involved in Glomerular Disease.

Authors:  A Richard Kitching; Holly L Hutton
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-12       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.